TWD 37.6
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 90 Thousand TWD | -82.89% |
2022 | 526 Thousand TWD | 46.11% |
2021 | 360 Thousand TWD | -99.6% |
2020 | 90.76 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | - TWD | 0.0% |
2024 Q1 | - TWD | -100.0% |
2023 Q2 | - TWD | 0.0% |
2023 Q4 | 45 Thousand TWD | 0.0% |
2023 Q1 | - TWD | -100.0% |
2023 FY | 90 Thousand TWD | -82.89% |
2023 Q3 | 45 Thousand TWD | 0.0% |
2022 Q3 | 263 Thousand TWD | 0.0% |
2022 FY | 526 Thousand TWD | 46.11% |
2022 Q4 | 263 Thousand TWD | 0.0% |
2021 FY | 360 Thousand TWD | -99.6% |
2020 FY | 90.76 Million TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 728 Thousand TWD | 87.637% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 1.11 Billion TWD | 99.992% |
Level Biotechnology Inc. | 660.61 Million TWD | 99.986% |
Sagittarius Life Science Corp | 440.46 Million TWD | 99.98% |
NeoCore Technology Co., Ltd. | 64.72 Million TWD | 99.861% |
TaiMed Biologics Inc. | 491.77 Million TWD | 99.982% |
GlycoNex Incorporation | 2.54 Million TWD | 96.459% |
VBI | 55.85 Million TWD | 99.839% |
GeneReach Biotechnology Corp. | 225.46 Million TWD | 99.96% |
Taiwan Advance Bio-Pharmaceutical Inc. | 315.98 Million TWD | 99.972% |
SynCore Biotechnology Co.,Ltd | 20.19 Million TWD | 99.554% |
Genomics BioSci & Tech. Co.,Ltd. | 396.14 Million TWD | 99.977% |
Visgeneer Inc. | 147.99 Million TWD | 99.939% |
Mycenax Biotech Inc. | 652.62 Million TWD | 99.986% |
Sunmax Biotechnology Co., Ltd. | 1.68 Billion TWD | 99.995% |
G&E Herbal Biotechnology Co., Ltd. | 181.44 Million TWD | 99.95% |
Neith Corporation | 39.9 Million TWD | 99.774% |
Medigen Vaccine Biologics Corporation | 389.62 Million TWD | 99.977% |
TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | 99.604% |
Enimmune corporation | 43.49 Million TWD | 99.793% |
TaiRx, Inc. | 5.08 Million TWD | 98.229% |
CHO Pharma, Inc. | - TWD | -Infinity% |
EirGenix Inc. | 1.02 Billion TWD | 99.991% |
BioLASCO Taiwan Co., Ltd. | 264.72 Million TWD | 99.966% |
Sunny Pharmtech Inc. | 428.82 Million TWD | 99.979% |
Lin BioScience, Inc. | - TWD | -Infinity% |
BioGend Therapeutics Co., Ltd. | 109.9 Million TWD | 99.918% |
Feng Chi Biotech Corp. | 180.57 Million TWD | 99.95% |
Bio Preventive Medicine Corp. | 1.2 Million TWD | 92.55% |
Lukas Biomedical Inc. | 231.83 Million TWD | 99.961% |
RBC Bioscience Corporation | 172.46 Million TWD | 99.948% |
BiOptic Inc. | 228.26 Million TWD | 99.961% |
Shine-On BioMedical Co.,Ltd. | 9.52 Million TWD | 99.055% |
Great Novel Therapeutics Biotech & Medicals | 4.85 Million TWD | 98.144% |
Syngen Biotech Co.,Ltd. | 1.83 Billion TWD | 99.995% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
NaviFUS Corp. | 22.48 Million TWD | 99.6% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 141.17 Million TWD | 99.936% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 805 Thousand TWD | 88.82% |
Greenyn Biotechnology Co., Ltd | 800.51 Million TWD | 99.989% |
Lumosa Therapeutics Co., Ltd. | 56.91 Million TWD | 99.842% |
AP Biosciences Inc | 32.25 Million TWD | 99.721% |
Medigen Biotechnology Corp. | 1.15 Billion TWD | 99.992% |
3D Global Biotech Inc. | 20.63 Million TWD | 99.564% |
Pharmosa Biopharm Inc. | 314.5 Million TWD | 99.971% |
Intech Biopharm Corporation | 25.84 Million TWD | 99.652% |
Oneness Biotech Co., Ltd. | 86.78 Million TWD | 99.896% |
Eusol Biotech Co.,Ltd. | - TWD | -Infinity% |
TWi Biotechnology, Inc. | - TWD | -Infinity% |
Ever Supreme Bio Technology Co., Ltd | 758.39 Million TWD | 99.988% |
TCI GENE Inc. | 333.85 Million TWD | 99.973% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -400.0% |
Senhwa Biosciences, Inc. | 1 Million TWD | 91.0% |
Taiwan Bio Therapeutics Co., Ltd | 85.47 Million TWD | 99.895% |
NatureWise Biotech & Medicals Corporation | 160.14 Million TWD | 99.944% |
PharmaEngine, Inc. | 767.66 Million TWD | 99.988% |
Savior Lifetec Corporation | 1.05 Billion TWD | 99.991% |
TaiGen Biopharmaceuticals Holdings Limited | 123.13 Million TWD | 99.927% |
OBI Pharma, Inc. | 41.54 Million TWD | 99.783% |
Meribank Biotech Co., Ltd | 234.34 Million TWD | 99.962% |
Acepodia, Inc. | 16.59 Million TWD | 99.458% |
Caliway Biopharmaceuticals Co., Ltd. | 38.93 Million TWD | 99.769% |